| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director, 10% Owner, See Remarks. | Director, 10% Owner, See Remarks
4 companies
Rubric Capital Management LP serves as a 10% Owner at HRTX and has filed Form 4s across 4 companies. Across recent SEC filings that breaks down to 10 buys and 24 sells. Those positions are worth an estimated $1.8B at current prices.
Historically, Rubric Capital Management LP's trades have earned a below-average insider score of 41/100 across 15 rated trades. Over a 12-month horizon, 8.3% of those trades were profitable, with an average 12-month return of -42.5%.
The biggest single holding is TLN (~$1.7B) as 10% Owner. The recent filings there lean toward selling, a net 5,282,037 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 13, 2025 | COLL Collegium Pharmaceutical, Inc | 10% Owner | Sell | 25,000 | $37.85 | $946,250.00 | -0.8% | +18.4% | -25.6% | |
| Aug 8, 2025 | HRTX Heron Therapeutics, Inc. /de/ | 10% Owner | Buy | 2,387,225 | $1.50 | $3,580,837.50 | +8.9% | -16.7% | -62.9% | |
| Jun 27, 2025 | TLN Talen Energy Corp | 10% Owner | Sell | 388,530 | $293.65 | $114,091,989.54 | -6.3% | +37.9% | +35.7% | |
| Dec 13, 2024 | TLN Talen Energy Corp | 10% Owner | Sell | 4,893,507 | $204.35 | $999,999,899.87 | -43.0% | -5.9% | +71.8% | |
| Dec 30, 2022 | TXMD Therapeuticsmd, Inc. | 10% Owner | Sell | 29,000 | $1,333.00 | $38,657,000.00 | -100% | -33.8% | -59.7% | |
| Dec 9, 2022 | TXMD Therapeuticsmd, Inc. | 10% Owner | Buy | 14,825 | $6.09 | $90,284.25 | +0.9% | -32.1% | -67.6% | |
| Dec 8, 2022 | TXMD Therapeuticsmd, Inc. | 10% Owner | Buy | 20,413 | $5.66 | $115,638.86 | +1.2% | -21.9% | -65.2% | |
| Oct 28, 2022 | TXMD Therapeuticsmd, Inc. | 10% Owner | Buy | 7,000 | $1,000.00 | $7,000,000.00 | +31.8% | -14.8% | -66.3% | |
| Sep 30, 2022 | TXMD Therapeuticsmd, Inc. | 10% Owner | Buy | 7,000 | $1,000.00 | $7,000,000.00 | +46.7% | -15.2% | -54.5% | |
| Jul 29, 2022 | TXMD Therapeuticsmd, Inc. | 10% Owner | Buy | 580,000 | $25.86 | $14,999,950.00 | -102.7% | -4.6% | -35.8% |